WASHINGTON, April 18 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration (DEA) has issued a notice that Restek Corporation, headquartered at 110 Benner Circle in Bellefonte, Pennsylvania, has applied to become a registered bulk manufacturer of numerous Schedule I controlled substances. The application, filed on February 19, 2025, outlines the company's intent to synthesize substances for DEA-exempted certified reference materials, bolstering domestic capacity for analy . . .

Click here for more information about our products